{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:25:00Z","timestamp":1792121100580,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jcyt.2023.11.003","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T14:55:54Z","timestamp":1701528954000},"page":"531-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative study"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2270-4821","authenticated-orcid":false,"given":"Beth H.","family":"Shaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6731-9516","authenticated-orcid":false,"given":"Magali J.","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-0996","authenticated-orcid":false,"given":"David H.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anna","family":"Reems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5867-3265","authenticated-orcid":false,"given":"David","family":"Stroncek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoko","family":"Tanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-6934","authenticated-orcid":false,"given":"Denese","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-5446","authenticated-orcid":false,"given":"Huimin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibani","family":"Pati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcyt.2023.11.003_bib0001","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/term.2914","article-title":"Mesenchymal stem cells: cell therapy and regeneration potential","volume":"13","author":"Brown","year":"2019","journal-title":"J Tissue Eng Regen Med"},{"issue":"7","key":"10.1016\/j.jcyt.2023.11.003_bib0002","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/stem.3016","article-title":"Concise review: mesenchymal stem cells: from roots to boost","volume":"37","author":"Andrzejewska","year":"2019","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.jcyt.2023.11.003_bib0003","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcyt.2013.11.004","article-title":"Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells","volume":"16","author":"Hemeda","year":"2014","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.jcyt.2023.11.003_bib0004","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jcyt.2019.06.006","article-title":"Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy","volume":"21","author":"Bieback","year":"2019","journal-title":"Cytotherapy"},{"issue":"12","key":"10.1016\/j.jcyt.2023.11.003_bib0005","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1111\/trf.14324","article-title":"Comparative analyses of industrial-scale human platelet lysate preparations","volume":"57","author":"Pierce","year":"2017","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.jcyt.2023.11.003_bib0006","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.transproceed.2011.01.021","article-title":"Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells","volume":"43","author":"Jenhani","year":"2011","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.jcyt.2023.11.003_bib0007","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jcyt.2019.04.053","article-title":"A highly standardized and characterized human platelet lysate for efficient and reproducible expansion of human bone marrow mesenchymal stromal cells","volume":"21","author":"Viau","year":"2019","journal-title":"Cytotherapy"},{"issue":"17","key":"10.1016\/j.jcyt.2023.11.003_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176284","article-title":"Human platelet lysate supports efficient expansion and stability of wharton's jelly mesenchymal stromal cells via active uptake and release of soluble regenerative factors","volume":"21","author":"Ca\u00f1as-Arboleda","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jcyt.2023.11.003_bib0009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12967-020-02489-4","article-title":"Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: a systematic review","volume":"18","author":"Guiotto","year":"2020","journal-title":"J Transl Med"},{"issue":"12","key":"10.1016\/j.jcyt.2023.11.003_bib0010","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jcyt.2013.06.014","article-title":"Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures","volume":"15","author":"Mojica-Henshaw","year":"2013","journal-title":"Cytotherapy"},{"issue":"20","key":"10.1016\/j.jcyt.2023.11.003_bib0011","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.1111\/jcmm.16912","article-title":"Human platelet lysate as a replacement for fetal bovine serum in human corneal stromal keratocyte and fibroblast culture","volume":"25","author":"Seidelmann","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jcyt.2023.11.003_bib0012","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fcell.2020.00458","article-title":"Human mesenchymal stromal cell (MSC) characteristics vary among laboratories when manufactured from the same source material: a report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) collaborative","volume":"8","author":"Stroncek","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.jcyt.2023.11.003_bib0013","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcyt.2014.04.002","article-title":"Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications","volume":"17","author":"Wuchter","year":"2015","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jcyt.2023.11.003_bib0014","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/stcltm\/szad009","article-title":"Feasibility study of cord tissue derived mesenchymal stromal cells in COVID-19-related acute respiratory distress syndrome","volume":"12","author":"Shaz","year":"2023","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2023.11.003_bib0015","unstructured":"R.C. Team, R: A language and environment for statistical computing, www.R-project.org; 2018 [accessed November 27, 2023]."},{"issue":"25","key":"10.1016\/j.jcyt.2023.11.003_bib0016","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.jcyt.2023.11.003_bib0017","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2003-4-9-r60","article-title":"DAVID: Database for Annotation, Visualization, and Integrated Discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biology"},{"issue":"10","key":"10.1016\/j.jcyt.2023.11.003_bib0018","doi-asserted-by":"crossref","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jcyt.2023.11.003_bib0019","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcyt.2018.10.014","article-title":"Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency","volume":"21","author":"Robb","year":"2019","journal-title":"Cytotherapy"},{"issue":"7","key":"10.1016\/j.jcyt.2023.11.003_bib0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/biomedicines8070220","article-title":"Inactivated platelet lysate supports the proliferation and immunomodulant characteristics of mesenchymal stromal cells in GMP culture conditions","volume":"8","author":"Mareschi","year":"2020","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.jcyt.2023.11.003_bib0021","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","article-title":"The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering","volume":"5","author":"Sutherland","year":"1996","journal-title":"J Hematother"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923011015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923011015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:38:37Z","timestamp":1728923917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923011015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1465324923011015"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.11.003","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative study","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}